Artificial intelligence has the capability to move beyond generic tools for the pharma industry. Commercial leaders discuss how purpose-built models can drive better decisions, keep human expertise at the center, and build lasting competitive advantage.
Every year, Pharmaceutical Executive recognizes rising leaders in the pharmaceutical and biotech industries. Our Emerging Pharma Leaders are nominated by their peers and come from every sector of the industry. This year, they all came together for a live roundtable discussion, where they took the time to explain how the biggest issues of the day impact them and their leadership styles.
As policy uncertainty, public scrutiny, and evolving regulations reshape the pharmaceutical landscape, business decisions have never carried greater strategic risk. Hear industry leaders discuss how they're navigating the intersection of policy, reputation, and corporate strategy to build resilience in an increasingly complex healthcare environment.
This Peer Exchange® centers on navigating the complexities of drug pricing, market access, and reimbursement through the balance of regulatory, payer, and patient perspectives using modern innovative approaches, partnerships, and technologies.
